Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-021302)

Filing Details

Accession Number:: 0001209191-22-021302
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-28 16:00:38
Reporting Period:: 2022-03-24

Accepted Time:: 2022-03-28 16:00:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Oncternal Therapeutics Inc.	ONCT	Pharmaceutical Preparations (2834)	621715807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1269341	G Richard Vincent	12230 El Camino Real, Suite 300 San Diego CA 92130	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-24	3	$1.45	83,165	No	4	P	Direct
Common Stock	Acquisiton	2022-03-25	356	$1.45	83,521	No	4	P	Direct
Common Stock	Acquisiton	2022-03-25	5	$1.48	83,526	No	4	P	Direct
Common Stock	Acquisiton	2022-03-25	2,136	$1.49	85,662	No	4	P	Direct
Common Stock	Acquisiton	2022-03-28	2,500	$1.40	88,162	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,526	Indirect	By Family Trust
Common Stock	1,834	Indirect	By Child